CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

SpringWorks Therapeutics - CapyFin

SpringWorks Therapeutics

SWTX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 6 months ago

Previous year: $21M

Previous year: -$1.18

Selling, general and administrative

Previous year: $60.1K

Research and development

Previous year: $53.6K

Cost of product revenue

Previous year: $1.2K

Cash and Equivalents

Previous year: $573M

Previous year: $657M

Loading...

Key Statistics

Market Cap

$3.54B

P/E Ratio

-13.76

Sector

N/A

Industry

N/A

52-Week High

$59.8

52-Week Low

$34.4

Selling, general and administrative

$76.5K

Research and development

$49.6K

Cost of product revenue

$3.53K

Equity-based compensation expense

$29.9K

Equity method investment loss

$1.65K

SpringWorks Therapeutics

Unlock previous datapoints

SpringWorks Therapeutics

Unlock previous datapoints

SpringWorks Therapeutics Revenue by Segment

SpringWorks Therapeutics Revenue by Geographic Location

Revenue by Segment

Product revenue, net Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...